Concepedia

Melinda S. Merchant

MS

Statistics

Publications

39

Citations

4.1K

H-Index

30

Active since

1993

Affiliations

National Cancer Institute(Current)

National Institutes of Health

Memorial Sloan Kettering Cancer Center

Center for Cancer Research

AstraZeneca (United States)

Melinda S. Merchant is an author at National Cancer Institute specializing in medicine, tumor biology, and immunology.

Top concepts

Publications per year

1993–2023

39

Publications

39

A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing's sarcoma

Hayriye V. Erkizan, Yali Kong, Melinda S. Merchant et al. · Nature Medicine · 2009 · 435 citations · Full text

, , +4

Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1 c259T Cells in Synovial Sarcoma

Sandra P. D’Angelo, Luca Melchiori, Melinda S. Merchant et al. · Cancer Discovery · 2018 · 418 citations · Full text

Phase I Clinical Trial of Ipilimumab in Pediatric Patients with Advanced Solid Tumors

Melinda S. Merchant, Matthew Wright, Kristin Baird et al. · Clinical Cancer Research · 2015 · 317 citations · Full text

Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1–2 trial

Kara L. Davis, Elizabeth Fox, Melinda S. Merchant et al. · The Lancet Oncology · 2020 · 307 citations · Full text

, , +4

Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell–depleted stem cell transplantation

Nirali N. Shah, Kristin Baird, Cynthia Delbrook et al. · Blood · 2014 · 233 citations · Full text

1–5 of 39